Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy studySusan E. Dorman, Samuel G. Schumacher, David Alland et al.|The Lancet Infectious Diseases|2017Cited by 688
MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis NetworkGiovanni Battista Migliori, José-María García-García, Simon Tiberi et al.|International Journal of Infectious Diseases|2020Cited by 226
A PGE2-MEF2A axis enables context-dependent control of inflammatory gene expressionFrancesco Cilenti, Renato Ostuni, Luca Mezzanzanica et al.|Immunity|2021Cited by 68
Integrated use of laboratory services for multiple infectious diseases in the WHO European Region during the COVID-19 pandemic and beyondDaniel Simões, Masoud Dara, Soudeh Ehsani et al.|Eurosurveillance|2022Cited by 9
Uptake of the lateral flow urine LAM test in Europe and Central AsiaChristian Kraef, Ole Kirk, Askar Yedilbayev et al.|The International Journal of Tuberculosis and Lung Disease|2022Cited by 9